Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
SQUAMOCIN
ID: ALA41177
Max Phase: Preclinical
Molecular Formula: C37H66O7
Molecular Weight: 622.93
Molecule Type: Small molecule
Associated Items:
ID: ALA41177
Max Phase: Preclinical
Molecular Formula: C37H66O7
Molecular Weight: 622.93
Molecule Type: Small molecule
Associated Items:
Synonyms (1): Squamocin
Synonyms from Alternative Forms(1):
Canonical SMILES: CCCCCC[C@H](O)CCC[C@H](O)[C@H]1CC[C@H]([C@H]2CC[C@H]([C@H](O)CCCCCCCCCCCCC3=C[C@H](C)OC3=O)O2)O1
Standard InChI: InChI=1S/C37H66O7/c1-3-4-5-15-19-30(38)20-17-22-32(40)34-24-26-36(44-34)35-25-23-33(43-35)31(39)21-16-13-11-9-7-6-8-10-12-14-18-29-27-28(2)42-37(29)41/h27-28,30-36,38-40H,3-26H2,1-2H3/t28-,30-,31+,32-,33+,34+,35+,36+/m0/s1
Standard InChI Key: DAEFUOXKPZLQMM-AUDZWCKFSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 622.93 | Molecular Weight (Monoisotopic): 622.4809 | AlogP: 7.86 | #Rotatable Bonds: 25 |
Polar Surface Area: 105.45 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 3 |
#RO5 Violations: 2 | HBA (Lipinski): 7 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 13.39 | CX Basic pKa: | CX LogP: 8.68 | CX LogD: 8.68 |
Aromatic Rings: 0 | Heavy Atoms: 44 | QED Weighted: 0.07 | Np Likeness Score: 1.82 |
1. Queiroz EF, Roblot F, Duret P, Figadère B, Gouyette A, Laprévote O, Serani L, Hocquemiller R.. (2000) Synthesis, spectroscopy, and cytotoxicity of glycosylated acetogenin derivatives as promising molecules for cancer therapy., 43 (8): [PMID:10780917] [10.1021/jm990568m] |
2. Nakanishi Y, Chang FR, Liaw CC, Wu YC, Bastow KF, Lee KH.. (2003) Acetogenins as selective inhibitors of the human ovarian 1A9 tumor cell line., 46 (15): [PMID:12852747] [10.1021/jm020548b] |
3. Gallardo T, Zafra-Polo MC, Tormo JR, González MC, Franck X, Estornell E, Cortes D.. (2000) Semisynthesis of antitumoral acetogenins: SAR of functionalized alkyl-chain bis-tetrahydrofuranic acetogenins, specific inhibitors of mitochondrial complex I., 43 (25): [PMID:11123988] [10.1021/jm000911j] |
4. Fall D, Duval RA, Gleye C, Laurens A, Hocquemiller R.. (2004) Chamuvarinin, an acetogenin bearing a tetrahydropyran ring from the roots of Uvaria chamae., 67 (6): [PMID:15217292] [10.1021/np030521a] |
5. Queiroz EF, Roblot F, Cavé A, Hocquemiller R, Serani L, Laprévote O, Paulo MQ.. (1999) A new bistetrahydrofuran acetogenin from the roots of Annona salzmanii., 62 (5): [PMID:10346951] [10.1021/np980482g] |
6. Queiroz EF, Roblot F, Figadère B, Laurens A, Duret P, Hocquemiller R, Cavé A, Serani L, Laprévote O, Cotte-Laffitte J, Quéro AM.. (1998) Three new bistetrahydrofuran acetogenins from the seeds of Annona spinescens., 61 (1): [PMID:9461649] [10.1021/np9703252] |
7. Rupprecht JK, Hui YH, McLaughlin JL.. (1990) Annonaceous acetogenins: a review., 53 (2): [PMID:2199608] [10.1021/np50068a001] |
8. Guadaño A, Gutiérrez C, de La Peña E, Cortes D, González-Coloma A.. (2000) Insecticidal and mutagenic evaluation of two annonaceous acetogenins., 63 (6): [PMID:10869199] [10.1021/np990328+] |
9. Yang H, Zhang N, Li X, Chen J, Cai B.. (2009) Structure-activity relationships of diverse annonaceous acetogenins against human tumor cells., 19 (8): [PMID:19285863] [10.1016/j.bmcl.2009.02.105] |
10. OHSAWA K, ATSUZAWA S, MITSUI T, YAMAMOTO I. (1991) Isolation and Insecticidal Activity of Three Acetogenins from Seeds of Pond Apple, Annona glabra L., 16 (1): [10.1584/jpestics.16.93] |
11. Shi JF, Wu P, Jiang ZH, Wei XY.. (2014) Synthesis and tumor cell growth inhibitory activity of biotinylated annonaceous acetogenins., 71 [PMID:24308999] [10.1016/j.ejmech.2013.11.012] |
Source(1):